Robert A. Bradway
Chairman, CEO and President at Amgen Inc. · b. 1963
Sits on 2 boards. Last updated September 28, 2026
Time on boards
- Boards served
- 2
- Current seats
- 2
- Board service
- 8 years
- Director since
- 2023
8 years of board service in total across 2 boards, counting each seat separately. Longest: The Boeing Company, 3 years.
Chief executive roles
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Amgen Inc. May 19, 202695.0%
-
The Boeing Company April 17, 202690.5%
-
Amgen Inc. May 23, 202593.4%
-
The Boeing Company April 24, 202592.8%
-
Amgen Inc. May 31, 202493.8%
-
The Boeing Company May 17, 202488.9%
-
Amgen Inc. May 19, 202393.8%
-
The Boeing Company April 18, 202396.1%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 7, 2026 | Amgen Inc. | Shares withheld for tax | −2,079 | $331.11 | $688,378 |
| May 6, 2026 | Amgen Inc. | Shares withheld for tax | −1,702 | $329.59 | $560,962 |
| May 5, 2026 | Amgen Inc. | Grant or award | +12,136 | — | — |
| May 2, 2026 | Amgen Inc. | Shares withheld for tax | −2,631 | $329.82 | $867,756 |
| May 2, 2026 | Amgen Inc. | Shares withheld for tax | −2,426 | $329.82 | $800,143 |
| Mar 16, 2026 | Amgen Inc. | Shares withheld for tax | −21,294 | $366.21 | $7,798,076 |
| Mar 4, 2026 | Amgen Inc. | Option exercise | +119,782 | $156.35 | $18,727,916 |
| Mar 4, 2026 | Amgen Inc. | Shares withheld for tax | −84,285 | $379.27 | $31,966,772 |
| Mar 3, 2026 | Amgen Inc. | Grant or award | +42,657 | — | — |
| May 6, 2025 | Amgen Inc. | Grant or award | +13,311 | — | — |
| May 2, 2025 | Amgen Inc. | Shares withheld for tax | −2,481 | $283.78 | $704,058 |
| May 2, 2025 | Amgen Inc. | Shares withheld for tax | −2,352 | $283.78 | $667,451 |
| Apr 30, 2025 | Amgen Inc. | Shares withheld for tax | −2,544 | $288.56 | $734,097 |
| Mar 17, 2025 | Amgen Inc. | Shares withheld for tax | −12,853 | $313.71 | $4,032,115 |
| Mar 3, 2025 | Amgen Inc. | Grant or award | +25,734 | — | — |
Questions about Robert A. Bradway
What boards is Robert A. Bradway on?
Robert A. Bradway sits on the boards of Amgen Inc. and The Boeing Company.
What company is Robert A. Bradway the CEO of?
Robert A. Bradway is Chairman, CEO and President of Amgen Inc.
How long has Robert A. Bradway served on boards?
Our records show at least 8 years of board service across 2 boards, the earliest from 2023.
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.